- the calamitous IPO
- the poor share price
- the loss of confidence of major holder -RA Capital
- complete miscommunication of 'efficacy' timelines
- delays continue in trial recruiting and reporting of clinical data
- PF being sacked without any real explanation
- no limit at all on the growth of director compensation, travel and expenses etc
- a few free options in there too to reward management for its 'good performance' - why not while they are at it!
I think you get the idea. Does anyone on here really think BLT leadership have any credibility left?
Add to My Watchlist
What is My Watchlist?